Will these FTSE-listed stocks be among the biggest winners during the next upturn? These five Fools are confident! AstraZeneca What it does: AstraZeneca is a global biopharmaceutical company specialising in oncology, rare diseases, cardiovascular, and other areas. By . ( ) is the largest company on the with a massive £191bn market cap.
Whenever a new bull market gets going, I reckon the pharma firm’s size could help drive a fair bit of it. The company is aiming to grow its revenue to $80bn between now and 2030. That would represent 75% growth, which would be impressive for an already giant business.
It’s also investing in “ ”. As part of this, it recently acquired biotech Fusion Pharmaceuticals for up to $2.4bn, as well as Gracell Biotechnologies, a pioneer in CAR-T cell therapies.
It’s also licensed an experimental pill from China’s Eccogene to try and break into the booming anti-obesity drug market. Investors tend to get more bullish about innovative growth stories like this during bull markets. Having said that, litigation is an ever-present risk in the industry, as are patent expirations, regulatory changes, and inevitable clinical trial disappointments.
Still, I reckon AstraZeneca has what it takes to continue outperforming the UK market over time. Burberry What is does: Burberry is a British luxury brand with 229 retail stores across the globe. By .
One sector I fully expect to be at the forefront of outsized gains in the next bull market, is luxury retail..